Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies

ConditionBone Disorder
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 99
SponsorUniversity Hospital, Toulouse

About this trial

The aim of this project is to set up a biological and clinical collection of patients with progressive bone, calcium and growth plate pathologies.

This collection will provide a better understanding of the mechanisms involved in growth plate and bone damage in these diseases and identify factors predictive of progression and new therapeutic targets.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children (from birth) with growth plate or bone pathology

Patients affiliated to or benefiting from a social security scheme

mastery of the French language

Not being subject to a restriction of rights by the judicial authorities

Disqualifiers

Patients under legal protection (guardianship, curatorship or safeguard of justice)

Pregnant or breast-feeding women

Trial population

Patients with with growth plate or bone pathology.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Biological samples

    Other intervention

    Blood and urine will be taken in larger quantity

  • Biological

    Other intervention

    Surgical residues may be preserved in the event of surgery carried out as part of the treatment.

Treatment groups

350 Participants
are divided into 1 treatment group
Group A: Patients suffering from growth plate or bone pathology2 interventions

Trial outcomes

Primary outcomes

1

Building a collection of biological samples and clinical-biological data from patients presenting bone, calcium and growth plate pathologies

Blood and urine sampling

Time frame
Day 0 and through study completion, an average of 5 years

Secondary outcomes

1

Identification of potential markers of disease progression based on new knowledge.

Time frame
Day 0 and through study completion, an average of 5 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.